HCID 86624030, compound → HCID 17751505, compound
Reaction equation
[K].C([O:9][C:10]1[CH:19]=[C:18]2[C:13]([CH:14]=[C:15]([O:21][CH3:22])[C:16](=[O:20])[O:17]2)=[CH:12][C:11]=1[N:23]1[S:27](=[O:29])(=[O:28])[NH:26][C:25](=[O:30])[CH2:24]1)C1C=CC=CC=1>O.[Pd]>[OH:9][C:10]1[CH:19]=[C:18]2[C:13]([CH:14]=[C:15]([O:21][CH3:22])[C:16](=[O:20])[O:17]2)=[CH:12][C:11]=1[N:23]1[S:27](=[O:29])(=[O:28])[NH:26][C:25](=[O:30])[CH2:24]1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 5-(7-benzyloxy-3-methoxy-2-oxo-2H-chromen-6-yl)-1,1-dioxo-1,2,5-thiadiazolidin-3-one potassium salt in water (10 mL), is added 10% Pd/C (0.014 g). The suspension is stirred under an atmosphere of H2 for 18 h. The aqueous solution is filtered through Celite and the water is removed by lyophilization. The crude solid is purified by preparative HPLC to afford 5-(7-hydroxy-3-methoxy-2-oxo-2H-chromen-6-yl)-1,1-dioxo-1,2,5-thiadiazolidin-3-one as a pale-yellow powder: 1H NMR (DMSO-d6) δ 7.66 (s, 1H), 7.27 (s, 1H), 6.77 (d, J=3.54 Hz, 1H), 4.03 (s, 2H), 3.77 (s, 3H); (M−H)−=325.
Workup
- filtrationThe aqueous solution is filtered through Celite
- customthe water is removed by lyophilization
- customThe crude solid is purified by preparative HPLC
Sources & evidence
- ORD record
- ord-afcf00e1b6194b75897faa71943889ef
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07700633B2
Reaction notes
Loading…